back to Australia directory
australia clinical guidance

Venous thromboembolism (DVT/PE)

A chapter-bounded Australian summary of venous thromboembolism (dvt/pe), using exact named Queensland PCCM content and any exact national source listed on this page.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Queensland PCCM DVT/PE is a Queensland implementation source. Apply only the cited chapter scope and verify the equivalent state or territory pathway.

Scope

Acute Australian assessment of suspected deep vein thrombosis or pulmonary embolism, using the national THANZ diagnostic framework and the Queensland PCCM DVT and PE chapters for rural escalation. This scope does not cover every thrombophilia, cancer or long-term anticoagulation decision.
sources for this section:THANZ VTE guidanceQueensland PCCM DVT/PE

The Bottom Line

  • Estimate clinical probability before selecting D-dimer or imaging; a test result must be interpreted within a coherent DVT or pulmonary-embolism pathway.
  • Ask about unilateral leg symptoms, previous VTE, immobility, surgery, cancer, pregnancy or postpartum status, oestrogen exposure and other provoking factors.
  • Suspected DVT requires timely medical consultation because an untreated proximal clot can embolise; suspected PE requires respiratory and haemodynamic assessment at first contact.
  • Anticoagulation choice and duration require the national guidance, current product information and individual bleeding, kidney, pregnancy and recurrence assessment.
sources for this section:THANZ VTE guidanceQueensland PCCM DVT/PE

Practical clinical workflow

1
Record complete observations, examine both legs and assess chest pain, breathlessness, syncope, haemoptysis and alternative diagnoses.
2
Use the applicable probability pathway to decide whether D-dimer, compression ultrasound or pulmonary vascular imaging is required.
3
If imaging is delayed, obtain senior advice on interim treatment rather than improvising a medicine regimen from an overseas pathway.
4
Document whether the event is provoked or unprovoked, arrange treatment monitoring and provide clear bleeding and recurrence advice.
sources for this section:THANZ VTE guidanceQueensland PCCM DVT/PE

Safety boundaries and escalation

  • Hypotension, hypoxaemia, syncope, severe respiratory distress or suspected massive pulmonary embolism requires immediate emergency and retrieval escalation.
  • Do not start, withhold or reverse anticoagulation without checking active bleeding, pregnancy, kidney function, interactions and the current local protocol.
sources for this section:THANZ VTE guidanceQueensland PCCM DVT/PE

Implementation

Queensland PCCM DVT/PE is a Queensland source. It supplies an Australian implementation example, not a national rule. Confirm the equivalent pathway, referral destination and medicine policy in the patient’s state or territory. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:THANZ VTE guidanceQueensland PCCM DVT/PE

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:THANZ VTE guidanceQueensland PCCM DVT/PE

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Thrombosis and Haemostasis Society of Australia and New ZealandDiagnosis and management of venous thromboembolism: clinical guidanceDOI 10.5694/mja2.50004 · 2019 evidence-based guideline · accessed 2026-08-20
    view source
  2. Queensland Health and Royal Flying Doctor Service Queensland SectionPrimary Clinical Care Manual, 12th edition: Deep vein thrombosis and pulmonary embolismISBN 978-1-876560-22-5; Deep vein thrombosis and pulmonary embolism, pp. 119–121 · 12th edition 2025, v1.03 with updates through 21 July 2026; exact chapter at printed pages 119–121 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.